European Archives - Page 910 of 1157 - European Medical Journal

How to Implement Guidelines into Clinical Practice

National and international guidelines are available for almost all common diseases, and these should be applied when counselling patients.

The Treatment Approach of Idiopathic Inflammatory Myopathies

This commentary reflects our personal approach to the treatment of idiopathic inflammatory myopathies (IIM), also commonly referred to as myositis.

Sustaining Cancer Care Through Collaborative Stewardship

Cancer care has undergone rapid changes in recent years, providing dramatically improved outcomes for many patients.

Tackling the Inflammatory Burden of Psoriasis: A Multidisciplinary Approach

Prof Girolomoni provided an overview of psoriasis, considering how patients are frequently affected by other comorbidities.

Hereditary Angioedema: The Dawn of a New Era of Hereditary Angioedema Management

This symposium provided an overview of past, current, and future therapies and routes of administration for patients with hereditary angioedema (HAE).

Developments in the Treatment and Management of Psoriasis

The oral session consisted of a talk on the 2-year efficacy and safety of guselkumab in the treatment of moderate-to-severe psoriasis from the Phase III VOYAGE 1 trial.

Linking Pathophysiology to Clinical Options in Psoriasis: New Insights into Interleukin-23

Prof Costanzo welcomed attendees to the symposium and outlined the agenda before explaining the autoimmune pathophysiology that underlies psoriasis.

Editor’s Pick: Screening for Pancreatic Cancer: Current Status and Future Directions

Pancreatic ductal adenocarcinoma is a lethal disease for a multitude of reasons, including difficulty of early detection, early metastatic spread, and…

Hepatopulmonary Syndrome: Oxidative Stress and Physical Exercise

Hepatopulmonary syndrome (HPS) may be defined by hepatic disease, gas exchange abnormalities that may lead to hypoxaemia, and the presence of pulmonary…

Epidemiology, Health Economic Context, and Management of Chronic Kidney Diseases in Low and Middle-Income Countries: The Case of Morocco

There is a significant emerging burden of chronic kidney disease (CKD) and end-stage renal disease (ESRD) in low and middle-income countries.